Prevalence and antimicrobial resistance of Ureaplasma spp. and Mycoplasma hominis isolated from semen samples of infertile men in Shanghai, China from 2011 to 2016
- 103 Downloads
This study was conducted to estimate the prevalence and antimicrobial resistance rate of Ureaplasma spp. and Mycoplasma hominis that were isolated from the semen samples of infertile males in Shanghai, China from 2011 to 2016. A total of 5016 infertile males and 412 healthy male controls were examined. The cultivation, identification, and antimicrobial susceptibilities of Ureaplasma spp. and M. hominis were assessed by using a Mycoplasma IST kit that was performed in parallel to selective solid agar cultivation. The positive rate of genital Mycoplasma infections in infertile men from 2011 to 2016 was 30–55%, which initially decreased during the first four years and then increased in the last two. Two distinct high-risk age ranges of Mycoplasma infections were observed: 26–30 years (37.8%) and 31–35 years (30.7%). Semisynthetic tetracyclines and macrolide antibiotics were the most effective agents against Ureaplasma spp. Among the fluoroquinolones, sparfloxacin and levofloxacin were also effective. Antibiotic resistance of Ureaplasma spp. against tetracyclines and macrolide antibiotics in the last six years did not vary significantly. However, the rate of resistance to fluoroquinolones (except norfloxacin) and spectinomycin decreased in the last two years. The rate of genital Mycoplasma presence in infertile patients between the ages of 26 and 35 years in Shanghai was high. The prevalence of genital Mycoplasma decreased during the first four years and then increased, with a peak in 2016. Doxycycline, minocycline, josamycin, and sparfloxacin can be recommended for first-line empirical treatment of Mycoplasma infections in infertile men in Shanghai, China.
We thank LetPub (http://www.letpub.com) for its linguistic assistance during the preparation of this manuscript.
YHZ and HXM designed the study and drafted the manuscript. WMG and YY interpreted data and revised the manuscript critically for important intellectual content. All authors read and approved the final version of the manuscript.
Compliance with ethical standards
This study was initiated after receiving approval from the Institutional Review Board of the Shanghai Provincial Crops Hospital of the Chinese People’s Armed Police Forces and carried out according to the Helsinki Declaration. Informed patient consent was obtained from all the participants. Ethics committee approval for the study protocol and written informed consent were obtained for this study.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Data sharing statement
There will be no additional unpublished data from the study.
- 1.Weng SL, Chiu CM, Lin FM, Huang WC, Liang C, Yang T, Yang TL, Liu CY, Wu WY, Chang YA, Chang TH, Huang HD (2014) Bacterial communities in semen from men of infertile couples: metagenomic sequencing reveals relationships of seminal microbiota to semen quality. PLoS One 9:e110152CrossRefPubMedPubMedCentralGoogle Scholar
- 6.Zhou YH, Ma HX, Shi XX, Liu Y (2017) Ureaplasma spp. in male infertility and its relationship with semen quality and seminal plasma components. J Microbiol Immunol Infect (in press). pii: S1684-1182(17)30071-3. https://doi.org/10.1016/j.jmii.2016.09.004
- 7.García-Castillo M, Morosini MI, Gálvez M, Baquero F, del Campo R, Meseguer MA (2008) Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates. J Antimicrob Chemother 62:1027–1030. https://doi.org/10.1093/jac/dkn337 CrossRefPubMedGoogle Scholar
- 8.Leli C, Mencacci A, Bombaci JC, D’Alò F, Farinelli S, Vitali M, Montagna P, Bietolini C, Meucci M, Perito S, Bistoni F (2012) Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in a population of Italian and immigrant outpatients. Infez Med 20(2):82–87PubMedGoogle Scholar
- 9.Waites KB, Bébéar CM, Robertson JA, Talkington DF, Kenny GE (2001) Cumitech 34, laboratory diagnosis of mycoplasmal infections. Nolte FS, coordinating editor, American Society for Microbiology, Washington DC, pp 1–30Google Scholar
- 16.Salmeri M, Valenti D, La Vignera S, Bellanca S, Morello A, Toscano MA, Mastrojeni S, Calogero AE (2012) Prevalence of Ureaplasma urealyticum and Mycoplasma hominis infection in unselected infertile men. J Chemother 24(2):81–86. https://doi.org/10.1179/1120009X12Z.00000000021 CrossRefPubMedGoogle Scholar
- 17.Abusarah EA, Awwad ZM, Charvalos E, Shehabi AA (2013) Molecular detection of potential sexually transmitted pathogens in semen and urine specimens of infertile and fertile males. Diagn Microbiol Infect Dis 77(4):283–286. https://doi.org/10.1016/j.diagmicrobio.2013.05.018 CrossRefPubMedGoogle Scholar
- 24.Song T, Ye A, Xie X, Huang J, Ruan Z, Kong Y, Song J, Wang Y, Chen J, Zhang J (2014) Epidemiological investigation and antimicrobial susceptibility analysis of Ureaplasma species and Mycoplasma hominis in outpatients with genital manifestations. J Clin Pathol 67(9):817–820. https://doi.org/10.1136/jclinpath-2014-202248 CrossRefPubMedGoogle Scholar
- 25.Schneider SC, Tinguely R, Droz S, Hilty M, Donà V, Bodmer T, Endimiani A (2015) Antibiotic susceptibility and sequence type distribution of Ureaplasma species isolated from genital samples in Switzerland. Antimicrob Agents Chemother 59(10):6026–6031. https://doi.org/10.1128/AAC.00895-15 CrossRefPubMedPubMedCentralGoogle Scholar
- 27.Clinical and Laboratory Standards Institute (CLSI) (2011) Methods for antimicrobial susceptibility testing for human mycoplasmas; approved guideline. CLSI document M43-A. CLSI, Wayne, PAGoogle Scholar